NGM Biopharmaceuticals, Inc.
HTRA1-BINDING AGENTS AND METHODS OF USE THEREOF
Last updated:
Abstract:
The present disclosure provides binding agents, such as antibodies, that specifically bind HTRA1, including human HTRA1, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising and expressing the binding agents.
Status:
Application
Type:
Utility
Filling date:
7 Feb 2022
Issue date:
11 Aug 2022